Serial Number
88854341
Owner
Nour Heart, Inc.Attorney
Jessica ConnarnFirst Use Date
Jun 15, 2021
Filing Date
Mar 31, 2020
NOUREXAL Trademark
Serial Number: 88854341 • Registration: 7304896
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
March 31, 2020
Registration Date
February 13, 2024
First Use Anywhere
June 15, 2021
First Use in Commerce
August 2, 2021
Published for Opposition
September 19, 2023
Goods & Services
Anti-inflammatories; Cardiovascular treatment preparations; Cardiovascular pharmaceuticals; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, injectables and pharmaceutical preparations for the treatment of cardiovascular disorders; Cardiovascular prevention preparations; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, injectables and pharmaceutical preparations for the prevention of cardiovascular disorders; Pharmaceutical preparations and substances for the treatment of aging and aging-related diseases, as well as viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, Alzheimer, gastrointestinal, hormonal, dermatological, psychiatric, mental depression and immune system related diseases and disorders; Pharmaceutical preparations and substances for the prevention of ischemia-dependent aging and aging-related diseases, including musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, Alzheimer, hormonal, dermatological, psychiatric, mental depression and immune system related diseases and disorders; Neurological Pharmaceuticals; Neurological treatment preparations; Musculoskeletal Pharmaceuticals; Vascular Pharmaceuticals; Pharmaceuticals for Prevention of Ischemic Injury; Pharmaceuticals for Prevention of Disease Progression; Cellular Energy Preservation Pharmaceuticals
